Found: 24
Select item for more details and to access through your institution.
An Adapted Neural-Fuzzy Inference System Model Using Preprocessed Balance Data to Improve the Predictive Accuracy of Warfarin Maintenance Dosing in Patients After Heart Valve Replacement.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 879, doi. 10.1007/s10557-021-07191-1
- By:
- Publication type:
- Article
Evolving Roles of Optimal Medical Therapy and PCI in Chronic Coronary Syndrome Patients with Stable Angina: Introduction.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 1005, doi. 10.1007/s10557-021-07185-z
- By:
- Publication type:
- Article
Effects of Major Antihypertensive Drug Classes on Erectile Function: a Network Meta-analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 903, doi. 10.1007/s10557-021-07197-9
- By:
- Publication type:
- Article
Mirabegron Ameliorated Atherosclerosis of ApoE<sup>−/−</sup> Mice in Chronic Intermittent Hypoxia but Not in Normoxia.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 805, doi. 10.1007/s10557-021-07196-w
- By:
- Publication type:
- Article
The Impact of the ISCHEMIA Trial on Clinical Practice: an Interventionist's Perspective.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 1019, doi. 10.1007/s10557-021-07230-x
- By:
- Publication type:
- Article
Opioids in Acute Coronary Syndromes: Friend or Foe?
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 1001, doi. 10.1007/s10557-022-07364-6
- By:
- Publication type:
- Article
Optimal Medical Therapy as First-Line Therapy for Chronic Coronary Syndromes: Lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Effect of Paclitaxel-Coated Balloon Angioplasty on Side Branch Lesion and Cardiovascular Outcomes in Patients with De Novo True Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 859, doi. 10.1007/s10557-021-07225-8
- By:
- Publication type:
- Article
Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 925, doi. 10.1007/s10557-021-07221-y
- By:
- Publication type:
- Article
Ticagrelor and Dapagliflozin Have Additive Effects in Ameliorating Diabetic Nephropathy in Mice with Type-2 Diabetes Mellitus.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 829, doi. 10.1007/s10557-021-07222-x
- By:
- Publication type:
- Article
Early Myocardial Dysfunction and Benefits of Cardiac Treatment in Young X-Linked Duchenne Muscular Dystrophy Mice.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 793, doi. 10.1007/s10557-021-07218-7
- By:
- Publication type:
- Article
What Is the Role of Assessing Ischemia to Optimize Therapy and Outcomes for Patients with Stable Angina and Non-obstructed Coronary Arteries?
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 1027, doi. 10.1007/s10557-021-07179-x
- By:
- Publication type:
- Article
Morphine Prevents Ischemia/Reperfusion-Induced Myocardial Mitochondrial Damage by Activating δ-opioid Receptor/EGFR/ROS Pathway.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 841, doi. 10.1007/s10557-021-07215-w
- By:
- Publication type:
- Article
The IL-6/STAT Signaling Pathway and PPARα Are Involved in Mediating the Dose-Dependent Cardioprotective Effects of Fenofibrate in 5-Fluorouracil-Induced Cardiotoxicity.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 817, doi. 10.1007/s10557-021-07214-x
- By:
- Publication type:
- Article
Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 973, doi. 10.1007/s10557-021-07211-0
- By:
- Publication type:
- Article
Five Years of Sacubitril/Valsartan—a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 915, doi. 10.1007/s10557-021-07210-1
- By:
- Publication type:
- Article
Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 951, doi. 10.1007/s10557-021-07209-8
- By:
- Publication type:
- Article
Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell–Derived Microvesicles to Repair the Ischemic Heart.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 933, doi. 10.1007/s10557-021-07208-9
- By:
- Publication type:
- Article
Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 959, doi. 10.1007/s10557-021-07205-y
- By:
- Publication type:
- Article
Efficacy and Safety of Low-Dose Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 991, doi. 10.1007/s10557-021-07202-1
- By:
- Publication type:
- Article
Arrhythmia Recurrence After Atrial Fibrillation Ablation: Impact of Warfarin vs. Non-Vitamin K Antagonist Oral Anticoagulants.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 891, doi. 10.1007/s10557-021-07200-3
- By:
- Publication type:
- Article
Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy Data.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 867, doi. 10.1007/s10557-021-07199-7
- By:
- Publication type:
- Article
Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 1011, doi. 10.1007/s10557-021-07198-8
- By:
- Publication type:
- Article